However, recent studies demonstrated that the IL-17/Th17 pathway may play a role in anti-mycobacterial immunity by recruiting neutrophils to the site of infection at the early stage of tuberculosis [25,26], or by accelerating the accumulation of Th1 cells and enhancing Th1 anti-mycobacterial responses [26–28]. Here, IL17A is linked to tuberculosis.